Milestone Pharmaceuticals Inc.
MIST
$2.15
$0.073.37%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -10.98% | -42.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.60% | -38.94% | |||
| Operating Income | 5.60% | 38.94% | |||
| Income Before Tax | 8.05% | 37.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.05% | 37.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.05% | 37.55% | |||
| EBIT | 5.60% | 38.94% | |||
| EBITDA | 5.59% | 39.00% | |||
| EPS Basic | 36.71% | 37.64% | |||
| Normalized Basic EPS | 36.77% | 37.64% | |||
| EPS Diluted | 36.71% | 37.64% | |||
| Normalized Diluted EPS | 36.77% | 37.64% | |||
| Average Basic Shares Outstanding | 45.37% | 0.14% | |||
| Average Diluted Shares Outstanding | 45.37% | 0.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||